Why the study?
Does pericardiocentesis with intrapericardial cisplatin instillation prevent fluid reaccumulation in patients with malignant pericardial effusion from esophageal cancer?
Does pericardiocentesis with intrapericardial cisplatin instillation prevent fluid reaccumulation in patients with malignant pericardial effusion from esophageal cancer?
Intrapericardial cisplatin instillation following pericardiocentesis appears safe and prevents fluid reaccumulation in patients with malignant pericardial effusion from esophageal cancer.
No takes yet. Share an insight, caveat, or question.
May support cisplatin instillation after pericardiocentesis in esophageal cancer effusion; leaves open confirmation in prospective trials.
Takatsugu Oida (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: